Featured Research

from universities, journals, and other organizations

Leishmaniasis: New Strategy To Find Drugs To Treat Neglected Parasitic Infection

Date:
November 10, 2009
Source:
University of Pittsburgh Schools of the Health Sciences
Summary:
Using an unconventional approach that they designed, drug discoverers have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases.

Using an unconventional approach that they designed, University of Pittsburgh drug discoverers and their collaborators at Walter Reed Army Institute of Research have identified compounds that hold promise for treating leishmaniasis, a parasitic infection that many consider one of the world's most overlooked diseases. The findings are available online today in PLoS Neglected Tropical Diseases.

These drug candidates, which are able to disrupt the growth of a certain stage in the life cycle of the parasite, were found by screening nearly 200,000 chemical compounds and then regrouping them into chemotypes or chemical classes, both new and known, explained senior investigator John S. Lazo, Ph.D., director of Pitt's Drug Discovery Institute and Allegheny Foundation Professor in the Department of Pharmacology and Chemical Biology, Pitt School of Medicine. One of the most potent compounds was further tested in a mouse model of leishmaniasis to confirm it could be effective against the infection.

"We are making real progress in our effort to find new drugs to treat what I'd call the most neglected of the neglected diseases," Dr. Lazo said. "And the method we've developed could be applied to find treatments for other parasitic infections, which are an enormous global health burden."

According to the U.S. Centers for Disease Control and Prevention, each year worldwide, there are about 1.5 million new cases of cutaneous leishmaniasis skin infections, which lead to ulcers, and about 500,000 visceral infections, which lead to fever, weight loss and enlargement of the spleen and liver,. There is no vaccine or drug to prevent the parasitic infection, which is transmitted through sandfly bites.

Interest in developing new treatments for leishmaniasis has grown because of the military presence in Afghanistan and Iraq, where the infection is common, said co-investigator Col. Alan Magill, M.D., director of the Division of Experimental Therapeutics at the Walter Reed Army Institute of Research, Silver Spring, Md.

"Our soldiers are at risk for becoming infected with the Leishmania parasite, but the treatments we have can produce serious side effects," he said. "Also, the organism is becoming resistant to those agents, which haven't changed in 50 years."

For the new study, lead investigator Elizabeth R. Sharlow, Ph.D., a research assistant professor in Pitt School of Medicine's Department of Pharmacology and Chemical Biology, took unconventional approaches to find drug candidates. First, she developed an assay based on the promastigote, the Leishmania life cycle stage that infects the sandfly, to measure the candidate's ability to inhibit the parasite's growth.

"Another unusual step we took was to screen compounds at relatively high concentration, which would make them more likely to affect promastigote growth," Dr. Sharlow said. "The aim was to maximize the diversity of the active compounds, which we then clustered into similar chemotypes with powerful computational methods to make further testing more manageable."

The researchers have dubbed this process "HILCES" for high throughput, low-stringency, computationally enhanced small molecule screening. Low stringency is the drug discovery term for high concentration.

A promising anti-leishmanial compound they found turned out to be disulfiram, or Antabuse, a drug that causes an acute sensitivity to alcohol and that is sometimes prescribed to discourage drinking among patients with chronic alcoholism. Testing in a mouse model of the infection showed that it could slow promastigote growth in a living organism, further demonstrating that the HILCES strategy can reveal effective, as well as unexpected, drug candidates.

"In a million years, we wouldn't have thought about using a compound such as disulfiram for leishmaniasis," noted Dr. Lazo. "It has appeal because it has already been widely used and is inexpensive, but in its current form, it might not be the best option to treat the infection. We plan to develop it further with our colleagues at Walter Reed to improve the compound's potency and efficacy."

All of the primary and confirmation screening data has been made available online, "so it can be data mined by medical researchers and industry anywhere in the world to identify and refine other anti-leishmanial drug candidates," Dr. Lazo added. "And, the same screening techniques could be invaluable to find compounds to treat other parasitic infections."

Other co-authors of the paper include David Close, B.S., Tong Ying Shun, Ph.D., Stephanie Leimgruber, M.S., Robyn Reed, M.S., all of the University of Pittsburgh Drug Discovery Institute and the Pittsburgh Molecular Library and Screening Center; Peter Wipf, Ph.D., Pitt Department of Chemistry; Gabriela Mustata, Ph.D., Department of Computational Biology, Pitt School of Medicine; and Capt. Jacob Johnson, Ph.D., Lt. Col. Michael O'Neil, Ph.D., and Col. Max Grogl, Ph.D., all of the Walter Reed Army Institute of Research.

The research was funded by grants from the U.S. Army and the National Institutes of Health.


Story Source:

The above story is based on materials provided by University of Pittsburgh Schools of the Health Sciences. Note: Materials may be edited for content and length.


Cite This Page:

University of Pittsburgh Schools of the Health Sciences. "Leishmaniasis: New Strategy To Find Drugs To Treat Neglected Parasitic Infection." ScienceDaily. ScienceDaily, 10 November 2009. <www.sciencedaily.com/releases/2009/11/091102204544.htm>.
University of Pittsburgh Schools of the Health Sciences. (2009, November 10). Leishmaniasis: New Strategy To Find Drugs To Treat Neglected Parasitic Infection. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2009/11/091102204544.htm
University of Pittsburgh Schools of the Health Sciences. "Leishmaniasis: New Strategy To Find Drugs To Treat Neglected Parasitic Infection." ScienceDaily. www.sciencedaily.com/releases/2009/11/091102204544.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Get on Your Bike! London Cycling Popularity Soars Despite Danger

Get on Your Bike! London Cycling Popularity Soars Despite Danger

AFP (Sep. 1, 2014) Wedged between buses, lorries and cars, cycling in London isn't for the faint hearted. Nevertheless the number of people choosing to bike in the British capital has doubled over the past 15 years. Duration: 02:27 Video provided by AFP
Powered by NewsLook.com
Can You Train Your Brain To Eat Healthy?

Can You Train Your Brain To Eat Healthy?

Newsy (Sep. 1, 2014) New research says if you condition yourself to eat healthy foods, eventually you'll crave them instead of junk food. Video provided by Newsy
Powered by NewsLook.com
We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins